Related Experiment Video

Updated: Jun 28, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years

Wayde M Weston1, Nicola P Klein

  • 1GlaxoSmithKline Biologicals, 2301 Renaissance Boulevard, RN0220, King of Prussia, PA 19406, USA. wayde.weston@gsk.com

Expert Review of Vaccines
|November 5, 2008
PubMed

Insights

A new combination vaccine, Kinrix, offers a diphtheria, tetanus, pertussis, and polio (DTaP-IPV) dose, reducing injections for children aged 4-6. This vaccine is safe and effective, supporting high immunization coverage rates.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatric Medicine

Background:

  • Combination vaccines simplify immunization schedules by consolidating multiple antigens into a single injection.
  • The DTaP-IPV vaccine (Kinrix) is now available in the USA for children aged 4-6 years.
  • This vaccine serves as the fifth dose of DTaP and the fourth dose of IPV.

Purpose of the Study:

  • To evaluate the immunogenicity and safety of the DTaP-IPV combination vaccine (Kinrix).
  • To assess the impact of Kinrix on reducing the number of required childhood vaccinations.

Main Methods:

  • Clinical trials were conducted in children aged 4-6 years.
  • Immunogenicity was assessed by measuring antibody responses to each vaccine component.
  • Safety was evaluated by monitoring adverse events.

Main Results:

  • Kinrix demonstrated robust immunogenicity in the target age group.
  • The safety profile of Kinrix was found to be comparable to separate DTaP and IPV vaccinations.
  • The use of Kinrix reduces the total number of injections needed for recommended immunizations.

Conclusions:

  • The DTaP-IPV combination vaccine (Kinrix) is an effective and safe option for children aged 4-6 years.
  • Utilizing combination vaccines like Kinrix can improve vaccination adherence and maintain high coverage rates.
  • This strategy contributes to sustained protection against diphtheria, tetanus, pertussis, and poliomyelitis.

More Related Videos

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Vaccinations01:51

Vaccinations

Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...